Caplyta

J&J's Tremfya roars into 2026 with massive January TV ad spend

For months, all signs have pointed to a looming dropoff in pharmas’ spending on TV ads. Johnson & Johnson’s Tremfya seems not to have gotten the memo.

Andrea Park Feb 11, 2026 12:33pm

AbbVie revs up Skyrizi spending to top TV ad totals in November

Dec 5, 2025 1:35pm

TV ad spending skyrocketed to new heights in October

Nov 7, 2025 12:17pm

FDA signs off on depression label expansion for J&J's Caplyta

Nov 6, 2025 8:43am

How J&J CEO broke a stalemate and won Intra-Cellular in M&A push

Feb 7, 2025 11:24am

J&J acquires CNS specialist Intra-Cellular for $14.6B

Jan 13, 2025 10:29am